Comprehensive analysis of clinical and biological value of ING family genes in liver cancer

doi:10.4251/wjgo.v16.i6.2592

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (646)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series.

Item

Count

PDF

HTML

446

Figures (1-9)

Sum=485

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=134

Publishing Process of This Article

Item

Count

Browse

Download

Sum=23

Jun 15, 2024 (publication date) through Jun 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2592-2609
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2592

Comprehensive analysis of clinical and biological value of ING family genes in liver cancer

Shi-Cai Liu

Shi-Cai Liu, School of Medical Information, Wannan Medical College, Wuhu 241002, Anhui Province, China

Author contributions: Liu SC collected and analyzed the data, conceptualized, designed, drafted and revised the manuscript, and approved the final version of the manuscript.

Supported by Talent Scientific Research Start-up Foundation of Wannan Medical College, No. WYRCQD2023045.

Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Shi-Cai Liu, PhD, Academic Research, School of Medical Information, Wannan Medical College, No. 22 Wenchang West Road, Higher Education Park, Wuhu 241002, Anhui Province, China. liushicainj@163.com

Received: January 2, 2024
Revised: March 17, 2024
Accepted: April 22, 2024
Published online: June 15, 2024
Processing time: 164 Days and 17.5 Hours

Core Tip

Core Tip: Liver cancer (LIHC) is a malignant tumor that occurs in the liver and has a high mortality in cancer. Comprehensive research of expression, mutation, prognosis, and biological mechanisms of ING family genes in LIHC is still lacking. We studied the expression profile, clinical relationship, prognostic potential and immune infiltration of ING family genes in LIHC. The relationship between ING family genes expression and tumor associated immune checkpoints was investigated in LIHC. The molecular mechanism of ING1-mediated hepatocarcinogenesis was preliminarily discussed. Our results highlight the potential mechanism and clinical value of ING family genes in treatment and prognosis of LIHC.